Deepinder Goyal, founder of Zomato, is scaling up production for his brain-health wearable startup, Temple, through strategic partnerships with manufacturing leaders Zetwerk and Ethereal Machines. The collaboration, reported on May 21, 2026, marks a significant step for Temple as it prepares to expand its market presence and device output.
Temple's Innovative Brain Health Device
Founded over a year ago, Temple develops wearable devices designed to continuously monitor brain blood flow. These devices utilize a sensor-based patch worn near the user's temple, offering a novel approach to preventive brain health monitoring. The company's technology is rooted in what Goyal refers to as the 'Gravity Ageing Hypothesis,' which posits that gravity's constant downward pull on blood over time can impede upward circulation to the brain, contributing to accelerated biological aging and cognitive decline. Temple's device aims to measure these crucial circulation patterns.
Strategic Manufacturing Partnerships
While Temple handles the primary manufacturing in-house, the new partnerships will streamline and accelerate production. Ethereal Machines will contribute to the precision manufacturing of specialized components, such as certain sensors. Zetwerk, known for its expertise in manufacturing scale-up, will manage the broader expansion of production capacity.
Temple has already begun shipping its initial batch of approximately 100 devices and plans to steadily increase output in the coming weeks. The startup is targeting an initial production of several thousand units, with ambitions to cater to both the Indian market and overseas territories, including the United States.
Funding and Investor Confidence
Temple has successfully raised approximately $54 million in funding, valuing the company at roughly $190 million. This substantial investment reflects strong confidence from a diverse group of backers, including prominent individual investors like Kunal Shah, Vijay Shekhar Sharma, Raj Shamani, Abhiraj Singh Bhal, Varun Alagh, and Akshant Goyal. Institutional investors such as Peak XV Partners, Info Edge, Vy Capital, and Steadview Capital have also contributed to Temple's funding rounds, underscoring the potential seen in its brain-health technology.